Wei AL, Li M, Li GQ, Wang X, Hu WM, Li ZL, Yuan J, Liu HY, Zhou LL, Li K, Li A, Fu MR. Oral microbiome and pancreatic cancer. World J Gastroenterol 2020; 26(48): 7679-7692 [PMID: 33505144 DOI: 10.3748/wjg.v26.i48.7679]
Corresponding Author of This Article
Ang Li, MD, Professor, Department of Pancreatic Surgery, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610000, Sichuan Province, China. angli@scu.edu.cn
Research Domain of This Article
Microbiology
Article-Type of This Article
Observational Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Dec 28, 2020; 26(48): 7679-7692 Published online Dec 28, 2020. doi: 10.3748/wjg.v26.i48.7679
Table 1 Demographic characteristics of participants
Variables
PDAC group, n = 41
Healthy control group, n = 69
P value
Age, average ± standard error
61.17 ± 1.79
64.64 ± 1.04
0.098
Gender, n (%)
Male
24 (59)
50 (72)
0.132
Female
17 (41)
19 (28)
BMI, average ± standard error
22.76 ± 0.94
24.44 ± 0.39
< 0.0001
Smoking history, n (%)
17 (41)
37 (54)
0.217
Alcohol consumption, n (%)
16 (39)
30 (43)
0.647
Dietary habit, n (%)
Oily and fatty food
25 (61)
21 (31)
0.002
Salty food
6 (15)
8 (11)
0.664
Light diet
10 (24)
40 (58)
0.001
Chronic disease, n (%)
Hypertension
1 (2)
15 (22)
0.006
Type II diabetes
2 (5)
6 (9)
0.714
Both
3 (7)
5 (7)
1.000
Loss of weight, n (%)
23 (56)
3 (4)
0.0001
Primary cancer site, n (%)
Head
31 (76)
NA
NA
Body and tail
10
Surgery, n (%)
Pancreaticoduodenectomy
14 (34)
NA
NA
Distal pancreatectomy
6 (15)
Palliative intervention techniques
21 (51)
AJCC staging
NA
NA
I-IIB
20 (49)
III-IV
21
Table 2 α-diversity indices of two groups
PDAC group, n = 41
Healthy control group, n = 69
P value
Shannon
5.14 ± 0.67
5.67 ± 0.51
0.0001
Simpson
0.90 ± 0.08
0.95 ± 0.02
0.0001
Chao1
423.48 ± 55.69
295.00 ± 54.05
0.0001
ACE
424.00 ± 55.72
293.97 ± 50.09
0.0001
Table 3 Flora abundance differences in pancreatic adenocarcinoma patients with symptomatic phenotype
Symptoms
Microbiome
Without symptoms
With symptoms
P value
Bloating
Porphyromonas
412.0 ± 394.3
660.4 ± 461.0
0.039
Fusobacteria
361.8 ± 184.4
490.0 ± 186.6
0.024
Alloprevotella
99.3 ± 81.9
155.4 ± 124.1
0.041
Jaundice
Prevotella
669.4 ± 384.3
403.2 ± 310.8
0.008
Dark brown urine
Veillonella
1863.8 ± 1449.2
1018.6 ± 766.7
0.035
Vomiting
Alloprevotella
130.3 ± 100.9
91.8 ± 134.4
0.036
Diarrhea
Neisseria
1360.3 ± 1256.6
3343.3± 1829.9
0.024
Campylobacter
74.9 ± 87.2
130.5 ± 59.7
0.034
Table 4 Oral bacteria distribution and risk of pancreatic adenocarcinoma
Odds ratio
95%CI
P value
Healthy control group
Base outcome
PDAC group
Age
0.956
0.875
1.046
0.327
BMI
0.973
0.708
1.338
0.866
Oily and fatty food
0.759
0.122
4.730
0.768
Streptococcus
5.344
1.282
22.282
0.021
Veillonella
0.187
0.055
0.631
0.007
Neisseria
0.309
0.100
0.952
0.041
Lactobacillus
0.713
0.357
1.425
0.338
Leptotrichia
6.886
1.423
33.337
0.016
Actinomyces
4.515
0.444
45.887
0.203
Haemophilus
1.185
0.513
2.738
0.691
Prevotella
0.673
0.298
1.519
0.341
Porphyromonas
0.294
0.084
1.033
0.056
Rothia
1.257
0.467
3.384
0.650
Fusobacterium
1.006
0.335
3.017
0.576
Citation: Wei AL, Li M, Li GQ, Wang X, Hu WM, Li ZL, Yuan J, Liu HY, Zhou LL, Li K, Li A, Fu MR. Oral microbiome and pancreatic cancer. World J Gastroenterol 2020; 26(48): 7679-7692